Metabolic Profiling Reveals Diagnostic Biomarkers for Distinguishing Myocarditis From Acute Myocardial Infarction
Conclusions: In conclusion, patients experiencing AMI and MC undergo significant metabolic reprogramming. Metabolites exhibiting abnormal expression in peripheral blood hold diagnostic value for distinguishing between AMI and MC in clinical settings. 11-cis-retinol proved to be the pivotal biomarker...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2025-01-01
|
| Col·lecció: | Cardiovascular Therapeutics |
| Accés en línia: | http://dx.doi.org/10.1155/cdr/6292099 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|